dipeptidyl peptidase-4 inhibitors
Dipeptidyl peptidase-4 inhibitors, also known as DPP-4 inhibitors, are a class of medications used primarily to manage type 2 diabetes. They work by blocking the action of an enzyme called dipeptidyl peptidase-4, which in turn helps regulate blood sugar levels by increasing the production of insulin and decreasing the release of a hormone that raises blood sugar.
Requires login.
Related Concepts (1)
Similar Concepts
- alpha-glucosidase inhibitors
- dapagliflozin
- dipeptidyl peptidase-4 (dpp-4) inhibitors
- dpp-4 inhibitors
- glp-1 receptor agonists
- glucagon-like peptide-1 (glp-1) receptor agonists
- glucagon-like peptide-1 receptor agonists
- incretin mimetics
- insulin analogs
- insulin analogues
- insulin receptor antagonist
- lipase inhibitors
- sglt-2 inhibitors
- sitagliptin
- sodium-glucose cotransporter-2 inhibitors